Blog

Data, Models, and Modalities: Key Themes from the Certainty 2026 Discovery UGM

A recap of the Certainty 2026 Discovery UGM in Boston, covering the top themes from…

CertaraJune 15, 2026

Announcement

Certara Integrates D360™ with Secondary Intelligence™ Software to Enhance Predicting Drug Safety Risk

Certara integrates D360 with Secondary Intelligence to help drug researchers identify off-target safety risks earlier…

CertaraJune 12, 2026

Video

Applying AI-Driven Biosimulation to Drug Discovery

Certara President Leif Pedersen explains how PBPK and QSP modeling, proven across 125+ FDA-approved drugs,…

CertaraJune 2, 2026

Blog

How to Choose the Right LLM for Medical Writing

What makes great GenAI medical writing software? See how medical writing artificial intelligence and model…

CertaraMay 28, 2026

Publication

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

This publication reports a pooled retrospective analysis evaluating growth patterns in children with B-Raf proto-oncogene…

Dorottya Gui-BodnarMay 28, 2026

Blog

Everything You Need to Know About CRFs in Clinical Trials

Read about the basics of CRFs and eCRF design, why annotated CRFs should be standardized…

CertaraMay 22, 2026

Blog

Best Practices for AI Prompt Engineering in Life Sciences

AI prompt engineering is an essential skill for using LLMs. Read our blog for best…

CertaraMay 22, 2026

Announcement

Modernizing the Academic Program and Retiring Chemicalize

Find key dates and details about discontinued academic licenses, Chemicalize retirement, and the transition to…

CertaraMay 21, 2026

Webinar

Controlling Clinical Data from Collection to Submission

CertaraMay 20, 2026

Blog

Best Practices for pharma commercialization in market access

Learn best practices for your pharma commercialization strategy. See how to localize content in pharma…

CertaraMay 12, 2026

Certara Products

Data, Models, and Modalities: Key Themes from the Certainty 2026 Discovery UGM

Certara Integrates D360™ with Secondary Intelligence™ Software to Enhance Predicting Drug Safety Risk

Applying AI-Driven Biosimulation to Drug Discovery

How to Choose the Right LLM for Medical Writing

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

Everything You Need to Know About CRFs in Clinical Trials

Best Practices for AI Prompt Engineering in Life Sciences

Modernizing the Academic Program and Retiring Chemicalize

Controlling Clinical Data from Collection to Submission

Best Practices for pharma commercialization in market access

Newsletter sign up

Quick links

Solutions

Contact